A variety of cardiac imaging tests can be used to assess cardiac masses. Cardiac magnetic resonance provides particular utility for this purpose, as it enables assessment of mass location, size, and tissue properties with high spatial and temporal resolution. This study (JCMR paper) provides a comprehensive evaluation of state of the art CMR methods for assessment of cardiac neoplasm and thrombus among a broad cohort of patients with systemic cancer. This JCMR paper and associated CMR materials will provide the reader with an understanding of the incremental utility of late gadolinium enhancement CMR for identification and prognostic risk stratification of patients with cardiac neoplasm and thrombus. Following this activity, learners will better understand incremental utility of late gadolinium enhancement CMR tissue characterization (as compared to conventional cine-CMR) for identification and prognostic risk stratification of cancer-associated cardiac neoplasm and thrombus.
The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Attend the sessions in full for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
The planners and faculty for this activity did not have any relationships to disclose.
Disclosure of Commercial Support
There is no commercial support of this activity.
Please see the bibliography at the end of the journal article.